Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-12 Tanguler Tolga EVP, Chief Commercial Officer Sale −19 $375.65 $7K 29,743
2026-01-12 Tanguler Tolga EVP, Chief Commercial Officer Sale −15 $377.82 $6K 29,728
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −39 $353.95 $14K 25,025
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −42 $355.16 $15K 24,983
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −41 $356.09 $15K 24,942
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −96 $357.17 $34K 24,846
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −123 $358.18 $44K 24,723
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −85 $359.14 $31K 24,638
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −155 $360.22 $56K 24,483
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −98 $361.45 $35K 24,385
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −73 $362.38 $26K 24,312
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −47 $363.55 $17K 24,265
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −199 $364.83 $73K 24,066
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −220 $365.56 $80K 23,846
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −50 $366.41 $18K 23,796
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −41 $367.40 $15K 23,755
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −92 $368.62 $34K 23,663
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −40 $369.48 $15K 23,623
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −19 $370.87 $7K 23,604
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −2 $372.46 $745 23,602

Page 15 of 41 · 816 trades